RAVULIZUMAB

UNII:	C3VX249T6L
Formula:
Preferred Substance Name:	RAVULIZUMAB

1803171-55-2
ALXN1210
ALXN-1210
IMMUNOGLOBULIN G2/G4, ANTI-(HUMAN COMPLEMENT C5) (HUMAN-MUS MUSCULUS ALXN1210 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS ALXN1210 .KAPPA.-CHAIN, DIMER
RAVULIZUMAB [INN]
RAVULIZUMAB [JAN]
RAVULIZUMAB [MI]
RAVULIZUMAB [USAN]
RAVULIZUMAB [WHO-DD]
RAVULIZUMAB CWVZ [WHO-DD]
RAVULIZUMAB-CWVZ
RAVULIZUMAB-CWVZ [PURPLE BOOK CDER]
ULTOMIRIS

Common Chemistry
i
Inxight Drugs
i
DailyMed Regulated Products
i
GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RAVULIZUMAB

Synonyms and Mappings

Resources